October 13, 2026
The first major lawsuit focused on "most favored nation" drug pricing efforts hit the courts last week. A bigger fight might be ahead as more mandatory programs emerge.
October 07, 2026
The pharmaceutical industry's top lobbying group asked a D.C. federal judge Wednesday to block a new Medicare rule tying Part B drug payments to prices abroad, claiming that the U.S. Department of Health and Human Services is imposing a "most-favored-nation" price control that Congress has repeatedly declined to enact.